Stocks and Investing Stocks and Investing
Wed, March 1, 2023
Tue, February 28, 2023

Douglas Tsao Reiterated (TBPH) at Strong Buy and Held Target at $19 on, Feb 28th, 2023


Published on 2024-10-28 01:59:03 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $19 on, Feb 28th, 2023.

Douglas has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas


  • David Risinger of "SVB Leerink" Maintained at Buy with Increased Target to $14 on, Thursday, November 17th, 2022

Contributing Sources